<DOC>
	<DOCNO>NCT00002419</DOCNO>
	<brief_summary>The purpose study see safe effective give adefovir dipivoxil plus abacavir ( ABC ) plus efavirenz ( EFV ) plus amprenavir ( APV ) HIV-infected patient fail respond previous treatment protease inhibitor ( PIs ) .</brief_summary>
	<brief_title>Safety Effectiveness Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir HIV-Infected Patients Who Have Failed Respond Previous Protease Inhibitor Treatment</brief_title>
	<detailed_description>Patients receive treatment regimen adefovir dipivoxil , abacavir , efavirenz , amprenavir 24 week . During study , patient evaluate change baseline plasma HIV-1 RNA level lymphocyte subset development adverse event toxicity . Patients experience virologic failure discontinue study . After Week 24 , patient document virologic response eligible continue receive study treatment attend schedule follow-up visit .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Amprenavir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive . Had HIV level least 2,000 copies/ml 6 month treatment least 1 PI amprenavir ( mean fail PI treatment ) . Are least 13 year old ( need consent parent guardian 18 ) . Are able complete study . Agree use effective barrier method birth control , condom , study . Exclusion Criteria You eligible study : Have certain serious medical condition , include AIDSrelated cancer ( except Kaposi 's sarcoma ) require treatment study . Have ever take allergic adefovir dipivoxil , ABC , APV , EFV . Are participate another antiHIV drug trial study . Have take certain medication within 30 day prior study entry , include medication affect immune system . Have diagnose hepatitis within past 30 day . Abuse alcohol drug . Are pregnant breastfeeding . Have ever take NNRTIs . Have ever take ddI d4T . Have receive chemotherapy radiation therapy within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>